Dr. Mary-Claire Roghmann

powered by
COS Expertise®
University of Maryland at Baltimore
Medicine
Epidemiology and Preventive Medicine
Healthcare Outomes Research
Associate ProfessorAppointed: 2002
VA Maryland Health Care System
Hospital EpidemiologistAppointed: 1997
Professional Headshot of Mary-Claire Roghmann

Mailing Address

Division of Healthcare Outcomes Research
100 N. Greene St. (Lower Level)
Baltimore, Maryland 21201
United States

Contact Information

Phone: (410) 706-0062
Fax: (410) 706-0098
mroghman@epi.umaryland.edu

Qualifications

M.S., University of Maryland at Baltimore, Epidemiology and Preventive Medicine, 1997.
M.D., Johns Hopkins University, 1990.

Expertise and Research Interests

Dr. Mary-Claire Roghmann is an infectious disease physician and epidemiologist studying emerging pathogens and healthcare acquired infections. She received her M.D. from the Johns Hopkins University School of Medicine and her M.S. from the Department of Epidemiology and Preventive Medicine at the University of Maryland. Dr. Roghmann is now Head of Division of Health Care Outcomes Research and an Associate Professor in the Department of Epidemiology and Preventive Medicine. She is also the Hospital Epidemiologist for the VA Maryland Health Care System.

Dr. Roghmann studies the epidemiology of antimicrobial-resistant pathogens such as methicillin-resistance S. aureus including risk factors for acquisition and infection and the impact on patients and the healthcare system. She has published over 30 papers and book chapters and mentored more than 20 faculty members, graduate students, fellows, residents and medical students. She has funding from the VA Research and Development and the Centers for Disease Control and Prevention (CDC) to study antibiotic resistance in the health care setting. Finally, she teaches clinical epidemiology as Education Director for the University of Maryland’s General Clinical Research Center and on the Department of Epidemiology and Preventive Medicine’s K30 grant.

Keywords

COS Keywords:

Antibiotics, Drug Resistance, Epidemiology, Infectious Diseases or Agents, Outcomes Research (Medical), Preventive Medicine.

Additional Terms:

Antibiotic Resistance, Cost Effectiveness, Nosocomial Infections.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)

Memberships

American College of Physicians
Infectious Diseases Society of America
Society for Healthcare Epidemiology of America

Previous Positions

2002-2007, Division Head, University of Maryland at Baltimore, Medicine, Epidemiology and Preventive Medicine, Healthcare Outomes Research
1997-2002, Assistant Professor, University of Maryland at Baltimore, Medicine, Epidemiology and Preventive Medicine, Healthcare Outomes Research

Funding Received

  • VA Research and Development Medical Research: Molecular Epidemiology of MRSA, $500,000, 2007 to 2011.
  • VA Research and Development Medical Research: Molecular Epidemiology of Antibiotic Resistance after Spinal Cord Injury, $420,000, 2003 to 2006.
  • Centers for Disease Control and Prevention: National Centers for Excellence in Healthcare Epidemiology, , 2001 to 2006.
  • National Institutes of Health (NIH): General Clinical Research Center, $15,222,533, 2001 to 2006.
  • Centers for Disease Control and Prevention Grant: The Clinical and Economic Impact of Antimicrobial Resistance on Nosocomial Infections in Intensive Care Units, $66,478, 2000 to 2002.
  • National Institutes of Health (NIH): Clinical Research Curriculum Award (K30), $921,546, 2000 to 2010.
  • VA Career Development Grant: The Epidemiology of Vancomycin-resistant Enterococcus (VRE), $117,300, 1998 to 2001.
  • National Institutes of Health (NIH): Evaluation of Vaccines and Therapeutics against Infectious Diseases other than AIDS in the Elderly and Adults, $785,312, 1998 to 2003.

Publications

  • Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC (Mar 2005) Risk of mortality with a bloodstream infection is higher in the less severely ill at admission., 171 (6), 616-20 Abstract
  • McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD (Mar 2005) Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms., 161 (5), 483-93 Abstract
  • Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, Edelman R, Fattom AI (Jan 2005) Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia., 59 (1), 27-32 Abstract
  • Roghmann M, Ball K, Erdman D, Lovchik J, Anderson LJ, Edelman R, Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation, Bone Marrow Transplantation, 32(11), 1085-8, December 2003 Abstract
  • Kim PW, Harris AD, Roghmann MC, Morris JG Jr, Strinivasan A, Perencevich EN, Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients, Antimicrobial Agents and Chemotherapy, 47(9), 2882-7, September 2003 Abstract
  • McCusker ME, Harris AD, Perencevich E, Roghmann MC, Fluoroquinolone use and Clostridium difficile-associated diarrhea, Emerging Infectious Diseases, 9(6), 730-3, June 2003 Abstract
  • Kim PW, Roghmann MC, Perencevich EN, Harris AD, Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites, American Journal of Infection Control, 31(2), 97-103, April 2003 Abstract
  • Kuruppu JC, Corretti M, Mackowiak P, Roghmann MC, Overuse of transthoracic echocardiography in the diagnosis of native valve endocarditis, Archives of Internal Medicine, 162(15), 1715-20, Aug 2002 Abstract
  • McCusker ME, Perisse AR, Roghmann MC, Severity-of-illness markers as predictors of nosocomial infection in adult intensive care unit patients, American Journal of Infection Control, 30(3), 139-44, May 2002 Abstract
  • Siddiqui AH, Perl TM, Conlon M, Donegan N, Roghmann MC, Preventing nosocomial transmission of pulmonary tuberculosis: when may isolation be discontinued for patients with suspected tuberculosis?, Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America., 23(3), 141-4, March 2002 Abstract
  • Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA, Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients, Antimicrobial Agents and Chemotherapy, 46(3), 854-8, March 2002 Abstract
  • Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC, Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America., 34(3), 340-5, February 2002 Abstract
  • Siddiqui AH, Harris AD, Hebden J, Wilson PD, Morris JG Jr, Roghmann MC, The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide, American Journal of Infection Control, 30(1), 40-3, February 2002 Abstract
  • Roghmann MC, Warner J, Mackowiak PA, The relationship between age and fever magnitude, The American Journal of the Medical Sciences, 322(2), 68-70, August 2001 Abstract
  • Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC, Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients, Surg Infect (larchmt), 2(1), 5-18, Spring 2001
  • Roghmann MC, Siddiqui A, Plaisance K, Standiford H, MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers, Journal of Hospital Infection, 47(2), 98-103, February 2001 Abstract
  • Roghmann MC, Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia, Archives of Internal Medicine, 160(7), 1001-4, 2000 Abstract
  • Fuss EP, Israel E, Baruch N, Roghmann MC, Improved tuberculosis infection control practices in Maryland acute care hospitals, American Journal of Infection Control, 28(2), 133-7, April 2000 Abstract
  • Roghmann MC, Sexton M, Adherence to asthma guidelines in general practices, Journal of Asthma, 36(4), 381-7, June 1999 Abstract
  • Pfundstein J, Roghmann MC, Schwalbe RS, Qaiyumi SQ, McCarter RJ, Keay S, Schweitzer E, Bartlett ST, Morris JG, Oldach DW, A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients, Clinical Transplantation, 13(3), 245-52, June 1999 Abstract
  • Roghmann MC, Faulkner CT, Lefkowitz A, Patton S, Zimmerman J, Morris JG, Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland, American Journal of Tropical Medicine and Hygiene, 60(5), 790-2, May 1999 Abstract
  • Roghmann MC, Perdue BE, Polish L, Vancomycin use in a hospital with vancomycin restriction, Infection Control and Hospital Epidemiology, 20(1), 60-3, Jan 1999 Abstract
  • Roghmann MC, Photo quiz. Pulmonary tuberculosis, Clinical Infectious Diseases, 27(5), 1137 1318-9, November 1998 Abstract
  • Roghmann MC, Fink JC, Polish L, Maker T, Brewrink J, Morris JG, Light PD, Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients, American Journal of Kidney Diseases, 32(2), 254-7, August 1998 Abstract
  • Roghmann MC, McCarter RJ, Brewrink J, Cross AS, Morris JG, Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia, Clinical Infectious Diseases, 25(5), 1056-9, November 1997 Abstract
  • Roghmann MC, Qaiyumi S, Schwalbe R, Morris JG, Natural history of colonization with vancomycin-resistant Enterococcus faecium, Infection Control and Hospital Epidemiology, 18(10), 679-80, October 1997 Abstract
  • Natsoulis G, Thomas W, Roghmann MC, Winston F, Boeke JD, Ty1 transposition in Saccharomyces cerevisiae is nonrandom, Genetics, 123(2), 269-79, October 1989 Abstract
  • Roghmann MC, Skinner KA, Hilf R, Effects of estradiol and tamoxifen on creatine kinase in rodent mammary carcinomas, Cancer Research, 47(5), 1348-53, March 1987 Abstract
  • Cerosaletti KM, Roghmann MC, Bentley DW, Comparison of latex agglutination and counterimmunoelectrophoresis for the detection of pneumococcal antigen in elderly pneumonia patients, Journal of Clinical Microbiology, 22(4), 553-7, October 1985 Abstract

Profile Details

Last Updated: 9/14/2007

COS Expertise ID #835706
Reference this profile directly: http://myprofile.cos.com/mroghman